Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group

BACKGROUND: International Metastatic Renal Cell Carcinoma (mRCC) Database Consortium (IMDC) risk groups are important when considering therapeutic options for first‐line treatment. MATERIALS AND METHODS: Adult patients with clear cell mRCC initiating first‐line sunitinib between 2010 and 2018 were i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Savard, Marie‐France, Wells, J. Connor, Graham, Jeffrey, Dudani, Shaan, Steinharter, John A., McGregor, Bradley A., Donskov, Frede, Bjarnason, Georg A., Vaishampayan, Ulka N., Hansen, Aaron R., Iafolla, Marco A.J., Zanotti, Giovanni, Huynh, Lynn, Chang, Rose, Duh, Mei S., Heng, Daniel Y.C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2020
Konular:
Genitourinary Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216460/
https://ncbi.nlm.nih.gov/pubmed/31971318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0605
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller